Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore ; volume:23 ; number:1 ; day:8 ; month:2 ; year:2023 ; pages:1-12 ; date:12.2023
BMC gastroenterology ; 23, Heft 1 (8.2.2023), 1-12, 12.2023
- Creator
-
Lee, Scott D.
Allegretti, Jessica R.
Steinwurz, Flavio
Connelly, Susan B.
Lawendy, Nervin
Paulissen, Jerome
Gecse, Krisztina B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-022-02508-2
- URN
-
urn:nbn:de:101:1-2023041221180647668999
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Scott D.
- Allegretti, Jessica R.
- Steinwurz, Flavio
- Connelly, Susan B.
- Lawendy, Nervin
- Paulissen, Jerome
- Gecse, Krisztina B.
- SpringerLink (Online service)
Other Objects (12)
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes